{
    "profile_id": "martijnbijker",
    "first_name": "Martijn",
    "last_name": "Bijker MBA, PhD",
    "sub_title": "Medical (Affairs) Director Immuno-Oncology Early Clinical Development (ph1-2), Biotech",
    "profile_picture": null,
    "background_image": "https://media.licdn.com/dms/image/C4E16AQEIC9C3cVpmQw/profile-displaybackgroundimage-shrink_350_1400/0/1620432226096?e=1697673600&v=beta&t=Idp-U7avO4_jAe_Y-OtyEOmL_AV8OdDUv8YYbkeYsaY",
    "profile_type": "personal",
    "entity_urn": "ACoAABfdH0EB_motF-zoWmDgGovp1t2T_eLdQFI",
    "object_urn": 400367425,
    "birth_date": null,
    "summary": "Experienced Medical (Affairs) Director with 20+ years of experience in immuno-oncology and oncology. Strong focus on R&D, phase 1-3 clinical trials and strategic positioning and integration of the medical affairs & MSL function in the wider pharmaceutical business to launch products to the market effectively. I love to build teams, departments and business from the ground up, and not afraid to take on any kind of role or job that needs to be done. I have experience in medical affairs. drug launch, regulatory & reimbursement,  marketing, pharmacovigilance and business analytics.",
    "location": {
        "country": null,
        "short": "Netherlands",
        "city": null,
        "state": null,
        "default": "Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            }
        ],
        "profile_languages": [
            {
                "name": "Dutch",
                "proficiency": "NATIVE_OR_BILINGUAL"
            },
            {
                "name": "English",
                "proficiency": "NATIVE_OR_BILINGUAL"
            }
        ]
    },
    "industry": "Pharmaceuticals",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2014
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2019
                }
            },
            "school": {
                "name": "Macquarie Business School",
                "logo": "https://media.licdn.com/dms/image/C560BAQEmzReB6pniYQ/company-logo_400_400/0/1671040289393?e=1700697600&v=beta&t=XX6AnQrPJPApyLm3tTAHC_U8dzYS-eKrjErDImVVaS4",
                "url": "https://www.linkedin.com/school/macquarie-business-school/"
            },
            "degree_name": "Master of Business Administration - MBA",
            "field_of_study": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2003
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2007
                }
            },
            "school": {
                "name": "Leiden University",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQEFlK1wNecYbA/company-logo_400_400/0/1519855876129?e=1700697600&v=beta&t=KwFN5kUM6lyLgjAXaylWnuNQ6g0XLwvWDjTK4Ug_mEg",
                "url": "https://www.linkedin.com/school/leiden-university/"
            },
            "degree_name": "Doctor of Philosophy - PhD",
            "field_of_study": "Immuno-Oncology /T cell cancer vaccines"
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2000
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2002
                }
            },
            "school": {
                "name": "Vrije Universiteit Amsterdam (VU Amsterdam)",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQGFG964atm3Ow/company-logo_400_400/0/1682661887840?e=1700697600&v=beta&t=bmk2N5LswEoQY_WJO0VySuxsWNNlfjU6XyPjkGaINeo",
                "url": "https://www.linkedin.com/school/vrije-universiteit-amsterdam/"
            },
            "degree_name": "Master of Science",
            "field_of_study": "Immuno-Oncology & Biochemistry"
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1996
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2000
                }
            },
            "school": {
                "name": "Vrije Universiteit Amsterdam (VU Amsterdam)",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQGFG964atm3Ow/company-logo_400_400/0/1682661887840?e=1700697600&v=beta&t=bmk2N5LswEoQY_WJO0VySuxsWNNlfjU6XyPjkGaINeo",
                "url": "https://www.linkedin.com/school/vrije-universiteit-amsterdam/"
            },
            "degree_name": "Bachelor of Science",
            "field_of_study": "Chemistry"
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [],
    "organizations": [],
    "projects": [
        {
            "title": "Nature interview: The changing landscape of pharma: a new route for PhDs?",
            "date": {
                "start": {
                    "month": 12,
                    "day": null,
                    "year": 2016
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2016
                }
            },
            "description": "Our recent interview with Nature (yes THE Nature) on the changing landscape of pharma and the fact that this will bring many opportunities for scientist like you having a PhD or doing a postdoc to start as a Medical Science Liaison (MSL) in the pharmaceutical industry. \nIt also covers why the demand for MSL roles is increasing  and why it is a good time for YOU to move now into an MSL role.\nIf you'd like the full article, please click below or on the picture.\nhttp://blogs.nature.com/naturejobs/?p=11253#more-11253",
            "contributors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Martijn",
                    "last_name": "Bijker MBA, PhD",
                    "name": null,
                    "headline": "Medical (Affairs) Director Immuno-Oncology Early Clinical Development (ph1-2), Biotech"
                }
            ]
        }
    ],
    "publications": [],
    "courses": [],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": 3997932,
                "name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQF0OKKTNPCXVw/company-logo_400_400/0/1679470329752?e=1700697600&v=beta&t=o_OfB1j9jM4wTDMeIYwz-CQpGe6cb-wkrbdXXH79RSc",
                "url": "https://www.linkedin.com/company/jiangsu-hengrui-pharmaceuticals/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2021
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Amsterdam, North Holland, Netherlands",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2021
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
                    "description": "In charge of bringing the pipeline of oncology products from JHP to Australia for phase 1,2 and 3 trials and engaging with the local KOLs to deliver on the study expectations.\n\nPipeline includes: TKI, IO, ADC, bi-specific Abs and combination therapy in breast, gastric, lung, GEJC, prostate, HCC and pancreatic cancer.",
                    "title": "Medical (Affairs) Director - Early (Immuno)Oncology Pipeline Development",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 1125502,
                "name": "Theramex",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQEIvNt7aOy4Ew/company-logo_400_400/0/1627307200367?e=1700697600&v=beta&t=OCy7dHi9QsjOVHqZoC-U3klOysdKukDuz3i8-YzHSos",
                "url": "https://www.linkedin.com/company/theramex/",
                "employees": {
                    "start": 201,
                    "end": 500
                }
            },
            "date": {
                "start": {
                    "month": 5,
                    "day": null,
                    "year": 2018
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2021
                }
            },
            "profile_positions": [
                {
                    "location": "Sydney, New South Wales, Australia",
                    "date": {
                        "start": {
                            "month": 5,
                            "day": null,
                            "year": 2018
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2021
                        }
                    },
                    "company": "Theramex",
                    "description": "*Successfully executed the divestment of the women\u2019s health portfolio from Teva to Theramex from a medical and compliance standpoint. *Leading the medical strategy of our women\u2019s health inline and pipeline products. \n*Relaunched established products\n*buikding a medical/MSL team for launching new women health products into the market\n*Overseeing promotional review and medical information\n*Responsible for pharmacovigilanceV(LPPV)\n*Performing business analyses (Ex-factory, IMS, PBS)\n*Wholesaler management and supply (2020Jan-Dec).",
                    "title": "Medical (Affairs) Director",
                    "employment_type": "Full-time"
                },
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2020
                        },
                        "end": {
                            "month": 3,
                            "day": null,
                            "year": 2021
                        }
                    },
                    "company": "Theramex",
                    "description": "Responsible for business analysis:\n-Ex-factory sales\n-IMS/IQVIA\n-PBS/Prospection",
                    "title": "Business Analyst",
                    "employment_type": "Part-time"
                },
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2019
                        },
                        "end": {
                            "month": 11,
                            "day": null,
                            "year": 2020
                        }
                    },
                    "company": "Theramex",
                    "description": null,
                    "title": "Australian Local Person of PharmacoVigilance (LPPV)",
                    "employment_type": "Part-time"
                }
            ]
        },
        {
            "company": {
                "id": 1485,
                "name": "Merck Group",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQE2ZjeYdi2Zsw/company-logo_400_400/0/1519856500274?e=1700697600&v=beta&t=wcGXfdkokYxpshK_hZ6P1xAUjwDAFOgc5sGGErlw_bw",
                "url": "https://www.linkedin.com/company/merck-group/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 9,
                    "day": null,
                    "year": 2015
                },
                "end": {
                    "month": 3,
                    "day": null,
                    "year": 2018
                }
            },
            "profile_positions": [
                {
                    "location": "Sydney",
                    "date": {
                        "start": {
                            "month": 12,
                            "day": null,
                            "year": 2016
                        },
                        "end": {
                            "month": 3,
                            "day": null,
                            "year": 2018
                        }
                    },
                    "company": "Merck Group",
                    "description": "Project-lead leading a team of functional directors in a joint-venture with Pfizer, to prepare the launch of our immuno-oncology pipeline in multiple tumour indications.",
                    "title": "Product Launch Lead immuno-oncology",
                    "employment_type": null
                },
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 8,
                            "day": null,
                            "year": 2016
                        },
                        "end": {
                            "month": 3,
                            "day": null,
                            "year": 2018
                        }
                    },
                    "company": "Merck Group",
                    "description": "Responsible for capturing, producing, editing and disseminating multichannel digital training for the medical and commercial teams.",
                    "title": "Digital strategy manager",
                    "employment_type": null
                },
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 9,
                            "day": null,
                            "year": 2015
                        },
                        "end": {
                            "month": 3,
                            "day": null,
                            "year": 2018
                        }
                    },
                    "company": "Merck Group",
                    "description": "As the biomarker manager i was responsible for:\n-reducing the national turn around time for colorectal pathology sample RAS testing\n-building and using an innovative platform \n-liaising with pathologists, healthcare providers and internal stakeholder. \n\nReduced the platform\u2019s turnaround time from an average 32 days to 11 days within a year.",
                    "title": "Biomarker MSL manager oncology",
                    "employment_type": null
                },
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2016
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2016
                        }
                    },
                    "company": "Merck Group",
                    "description": "Leading a team of MSLs to deliver on the medical strategy",
                    "title": "Acting Medical Advisor oncology/immuno-oncology",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 2068,
                "name": "Amgen",
                "logo": "https://media.licdn.com/dms/image/C560BAQGWIWAbjOEDEQ/company-logo_400_400/0/1674006648997?e=1700697600&v=beta&t=j0Eq4MmEyYJBehi_E3VoUErC5o5-vwgG2cWMn0Ql6Zo",
                "url": "https://www.linkedin.com/company/amgen/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 5,
                    "day": null,
                    "year": 2013
                },
                "end": {
                    "month": 8,
                    "day": null,
                    "year": 2015
                }
            },
            "profile_positions": [
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 5,
                            "day": null,
                            "year": 2013
                        },
                        "end": {
                            "month": 8,
                            "day": null,
                            "year": 2015
                        }
                    },
                    "company": "Amgen",
                    "description": "National MSL for:\n-immuno-oncology (Blinatumomab/Blincyto, T-vec/Imlygic) \n-haematology and oncology (Neulasta, Romiplostim)",
                    "title": "MSL - Immuno-oncology (haem/onc)",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 1304385,
                "name": "AbbVie",
                "logo": "https://media.licdn.com/dms/image/D560BAQFsLi_6JprdXg/company-logo_400_400/0/1688206283031?e=1700697600&v=beta&t=qZGfBJta8RSPMJBCTMUt-7Ckm8BTsj2Syej4ilNpujw",
                "url": "https://www.linkedin.com/company/abbvie/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2011
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2013
                }
            },
            "profile_positions": [
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": null,
                            "day": null,
                            "year": 2011
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": 2013
                        }
                    },
                    "company": "AbbVie",
                    "description": "National MSL for gastroenterology for Humira",
                    "title": "MSL - Immunology/Gastroenterology",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 42395,
                "name": "Garvan Institute of Medical Research",
                "logo": "https://media.licdn.com/dms/image/C560BAQEAah4TW1WmPA/company-logo_400_400/0/1678672604717?e=1700697600&v=beta&t=IdQteMyB_IlFBEIXcKVYUTp4pTx7hznMlXN-_Ytgl-c",
                "url": "https://www.linkedin.com/company/garvan-institute-of-medical-research/",
                "employees": {
                    "start": 501,
                    "end": 1000
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2008
                },
                "end": {
                    "month": 5,
                    "day": null,
                    "year": 2011
                }
            },
            "profile_positions": [
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2008
                        },
                        "end": {
                            "month": 5,
                            "day": null,
                            "year": 2011
                        }
                    },
                    "company": "Garvan Institute of Medical Research",
                    "description": "T cells and cancer and the role of neuropeptides\n3 fellowships:\nNHMRC\nDutch Cancer Society (KWF)\nDutch Society for Research (NWO Rubicon)",
                    "title": "Postdoctoral Researcher Immuno-Oncology",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 8586,
                "name": "Leiden University Medical Center",
                "logo": "https://media.licdn.com/dms/image/C560BAQH1qP661qZWFA/company-logo_400_400/0/1519856575224?e=1700697600&v=beta&t=wYpwmXXnVukk6whFb27PQo1Y9rqxOasYkkof8pIVSgY",
                "url": "https://www.linkedin.com/company/lumc/",
                "employees": {
                    "start": 5001,
                    "end": 10000
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 2003
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2007
                }
            },
            "profile_positions": [
                {
                    "location": "Leiden, The Netherlands",
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 2003
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2007
                        }
                    },
                    "company": "Leiden University Medical Center",
                    "description": "Immuno-Oncology /T cell cancer vaccines",
                    "title": "PHD Fellow Immuno-Oncology",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 33963,
                "name": "La Jolla Institute for Immunology",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQFOiGJ8uvN6RQ/company-logo_400_400/0/1540317103201?e=1700697600&v=beta&t=g6ecTeBnrGTPnCP_EooeYpoiayiv2Eg7liFYkND9cFo",
                "url": "https://www.linkedin.com/company/la-jolla-institute/",
                "employees": {
                    "start": 201,
                    "end": 500
                }
            },
            "date": {
                "start": {
                    "month": 2,
                    "day": null,
                    "year": 2002
                },
                "end": {
                    "month": 9,
                    "day": null,
                    "year": 2002
                }
            },
            "profile_positions": [
                {
                    "location": "San Diego, California",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2002
                        },
                        "end": {
                            "month": 9,
                            "day": null,
                            "year": 2002
                        }
                    },
                    "company": "La Jolla Institute for Immunology",
                    "description": "Dynamic programming of CD8+ T cell lymphocytes",
                    "title": "International Master student",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "Training Plans",
        "Development Studies",
        "Scientific Communications",
        "Advisory Boards",
        "Business Analysis",
        "Regulatory Compliance",
        "Antibodies",
        "Product Development",
        "Hematology",
        "Marketing",
        "Clinical Development",
        "Pharmacovigilance",
        "Product Launch",
        "MSL training",
        "Medical Science Liaison",
        "Medical Affairs",
        "immuno-oncology",
        "immunology",
        "Pharmaceutical Industry",
        "Biotechnology"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}